Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Biological Response Modifiers
|
August 1, 1986
Initial clinical studies with copovithane
G N Hortobagyi, E M Hersh, N E Papadopoulos, et al.
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Cancer
|
November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma
A Buzaid, S S Legha, C M Balch, et al.
Melanoma Research
|
October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results
A C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2010
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
A I Daud, C Xu, W-J Hwu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
Cancer
|
March 30, 2000
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy
O Eton, A C Buzaid, A Y Bedikian, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma
S Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Biological Response Modifiers
|
August 1, 1986
Initial clinical studies with copovithane
G N Hortobagyi, E M Hersh, N E Papadopoulos, et al.
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Cancer
|
November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma
A Buzaid, S S Legha, C M Balch, et al.
Melanoma Research
|
October 1, 1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results
A C Buzaid, E A Grimm, F Ali-Osman, et al.
Cancer Chemotherapy and Pharmacology
|
May 29, 2010
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
A I Daud, C Xu, W-J Hwu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
Cancer
|
March 30, 2000
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy
O Eton, A C Buzaid, A Y Bedikian, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma
S Vadhan-Raj, N E Papadopoulos, M A Burgess, et al.
Page
of 3